SG Americas Securities LLC Lowers Holdings in HealthEquity, Inc. $HQY

SG Americas Securities LLC reduced its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 21.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,563 shares of the company’s stock after selling 1,280 shares during the period. SG Americas Securities LLC’s holdings in HealthEquity were worth $478,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Invesco Ltd. raised its position in shares of HealthEquity by 50.6% in the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company’s stock worth $216,171,000 after buying an additional 821,425 shares in the last quarter. Nuveen LLC purchased a new position in HealthEquity during the first quarter worth about $53,076,000. Price T Rowe Associates Inc. MD increased its stake in HealthEquity by 995.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock worth $56,500,000 after acquiring an additional 580,988 shares during the last quarter. Westfield Capital Management Co. LP bought a new position in HealthEquity in the 1st quarter worth about $49,787,000. Finally, Ameriprise Financial Inc. raised its holdings in shares of HealthEquity by 148.1% in the 1st quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company’s stock valued at $59,203,000 after acquiring an additional 399,897 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Down 0.4%

HQY stock opened at $104.99 on Friday. The company has a market capitalization of $9.05 billion, a PE ratio of 63.63, a price-to-earnings-growth ratio of 1.36 and a beta of 0.47. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The company’s 50 day moving average price is $95.89 and its two-hundred day moving average price is $96.78.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $325.80 million for the quarter, compared to analyst estimates of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. As a group, analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Delano Ladd sold 6,000 shares of the stock in a transaction dated Friday, September 19th. The shares were sold at an average price of $94.11, for a total value of $564,660.00. Following the sale, the executive vice president owned 79,456 shares of the company’s stock, valued at $7,477,604.16. This represents a 7.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 10,781 shares of company stock worth $1,016,707. Company insiders own 1.50% of the company’s stock.

Analysts Set New Price Targets

HQY has been the subject of several recent analyst reports. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. BMO Capital Markets began coverage on shares of HealthEquity in a research report on Thursday, November 13th. They set a “market perform” rating and a $100.00 target price for the company. JPMorgan Chase & Co. increased their price target on shares of HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a report on Wednesday, September 3rd. Jefferies Financial Group raised their price objective on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, September 3rd. Finally, Barrington Research reiterated an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $119.00.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.